The Good
• Lowest Mortality rate due to Vaccination & Boosters
• Pfizer 5-11 years old booster approved
• 4th dose or 2nd booster effectiveness + Mix & Match data
The Bad
• 60% of US adults and 75% 5-11 years old got Omicron BA 1
• BA2 1.21 and BA 4-5 = higher viral load + more infectious = higher reinfection & breakthrough
The Ugly
• Real risk of Omicron is 15% risk (boosted) or 30% risk Unvaccinated for Long Covid
• Unclear size of new wave in the US due to @home diagnostic
• Omicron variants drive higher US hospitalization of over 35% in last 2 weeks
• Cumulative Covid Deaths: 15 million globally and 1 million in US
This is a science-based video on the latest scientific research on Omicron to help you make informed decision for yourself and your family. Sources include CDC, FDA, respected scientific data coming from John Hopkins, UCSF, Nature, JAMA and are typically posted on every slide with links.
N95 CDC approved list: cdc.gov/niosh/npptl/topics/respirators/disp_part/respsource3surgicaln95.html
Check my Time stamp captured text notes: tinyurl.com/yckzh249
Check Topic keyword search for video from 6-26-20 to 5-20-22 at tinyurl.com/4sbuex52
This regular update of the COVID-19, pandemic is narrated by Anne DeGheest. She is leveraging her healthcare network and access to experts with the latest scientific data and publications to paint a reliable picture of the virus' evolution and how it will impact us.
Disclaimer: Anne DeGheest is not a medical doctor and does not intend to provide any medical advice. Her sources are typically posted on every slide with links to published scientific papers and news reports. Please contact your physician before taking any supplements or medications discussed in these videos.
Anne DeGheest pioneered the HealthTech or Digital Health space as a healthcare executive, an entrepreneur, angel investor, corporate advisor and mentor capitalist. She is the founder of HealthTech Capital and MedStars. She launched pulse oximetry with Nellcor and several new hospital patient monitoring companies. Her life science portfolio companies have generated over $18 billion in market capitalization including 8 IPOs. She provided angel capital, hands-on executive leadership and/or business strategy in the founding of major venture-backed companies that changed patient monitoring and hospital care delivery, including the launch of pulse oximetry. She is a well-known keynote speaker and panelist at multiple healthcare conferences. Check her background at healthtechcapital.com/degheest
- Omicron BA 2 variants = 15-30% Long Covid Risk Covid update 5-20-22 ( Download)
- COVID Update for Aging Adults: Omicron BA.2 & More ( Download)
- BA 2 Omicron progresses ( Download)
- Omicron BA.2, Another Scary Daughter, Japanese Study ( Download)
- IS OMICRON BA2 THE NEXT WAVE 3-20-22 ( Download)
- BA.2.86 ( Download)
- OMICRON BA.4/5… 2.75! RISE OF THE SUBVARIANTS | 5 Natural Ways to Lower COVID Severity ( Download)
- Omicron subvariant BA 5 dominant strain in NC ( Download)
- Ep 107 Osterholm Update: A BA.4 and BA.5 World ( Download)
- BA.2.75 Evasion of Neutralizing Antibody Response ( Download)
- No, BA.5 Does NOT Cause More Severe Disease Than BA.1 or BA.2 ( Download)
- BA.5 Variant, Paxlovid, Novavax, Covid Vaccines for Children, and other Covid Updates! | IG LIVE ( Download)
- Covid Human Challenge Study ! Omicron BA2 Transmission Data & Highly Virulent HIV Variant discovered ( Download)
- BA.5, Paxlovid Rebound & What to Do about Boosters ( Download)
- Webinar #81 | “WHAT'S NEW NANDITO NA BA ANG OMICRON: Updates on COVID-19 Clinical Management” ( Download)
